Cargando…
Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
BACKGROUND: Patients with schizophrenia suffer high rates of metabolic derangements on some antipsychotic medications that predispose them to cardiovascular diseases. Keeping this fact in mind, we planned this open-label study to see the effect on various metabolic parameters after switching stable...
Autores principales: | Wani, Rayees Ahmad, Dar, Mansoor Ahmad, Chandel, Rajesh Kumar, Rather, Yasir Hassan, Haq, Inaamul, Hussain, Arshad, Malla, Altaf Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364593/ https://www.ncbi.nlm.nih.gov/pubmed/25792838 http://dx.doi.org/10.2147/NDT.S80925 |
Ejemplares similares
-
Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment
por: Wani, Rayees Ahmad, et al.
Publicado: (2015) -
Rapid Response of Long-Standing, Treatment-Resistant Non-Catatonic Mutism in Paranoid Schizophrenia with Single ECT session
por: Dar, Mansoor Ahmad, et al.
Publicado: (2014) -
Obsessive Compulsive Disorder Presenting as Neurological Emergency
por: Dar, Mansoor Ahmad, et al.
Publicado: (2015) -
Role of Lamotrigine Augmentation in Treatment-Resistant Obsessive Compulsive Disorder: A Retrospective Case Review from South Asia
por: Hussain, Arshad, et al.
Publicado: (2015) -
Prevalence of Psychiatric Disorders in Patients with a Diagnosis of Polycystic Ovary Syndrome in Kashmir
por: Hussain, Arshad, et al.
Publicado: (2015)